Effect of sodium–glucose cotransporter 2 inhibitors on cardiac structure and function in type 2 diabetes mellitus patients with or without chronic heart failure: a meta-analysis

BACKGROUND: Although the benefits of sodium–glucose cotransporter 2 inhibitors (SGLT2i) on cardiovascular events have been reported in patients with type 2 diabetes mellitus (T2DM) with or without heart failure (HF), the impact of SGLT2i on cardiac remodelling remains to be established. METHODS: We...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yi-Wen, Zhao, Xue-Mei, Wang, Yun-Hong, Zhou, Qiong, Huang, Yan, Zhai, Mei, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836497/
https://www.ncbi.nlm.nih.gov/pubmed/33494751
http://dx.doi.org/10.1186/s12933-020-01209-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836497/
https://www.ncbi.nlm.nih.gov/pubmed/33494751
http://dx.doi.org/10.1186/s12933-020-01209-y

Ejemplares similares